Algo version: 0.98b
ABUS is listed at the NASDAQ Exchange
ABUS [ABUS]
NASDAQ Sector: Healthcare Industry:Biotechnology

Is ABUS stock a buy?

What Is The Conclusion?

Right now our advanced algorithms say:

Do the analyst corps agree?

Interesting Questions and Easy Answers!

We cannot find any recorded dividends paid in our systems.

Sorry, we do not have any analyst data for this ticker

On Friday 21st of November 2014, Arbutus Biopharma had a stock price of $16.00. If you invested back then, your return now would be a loss of $-12.55 per share or -78.44%

Yes, the average daily trading liquidity for Arbutus Biopharma is $4.09 million. You should therefore be able to get in and out of your positions relatively fast.

Arbutus Biopharma has no real debt, which is good in periods of high inflation. The company is still not profitable, and high inflation will make it harder to become profitable as costs increase and consumer spending decreases.

We have calculated the inflation risk for Arbutus Biopharma to be medium [0.7 out of 1]